Medical Care
Global Liver Fibrosis Treatment Market Research Report 2025
- Mar 11, 25
- ID: 77627
- Pages: 74
- Figures: 79
- Views: 16
The global market for Liver Fibrosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liver Fibrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Fibrosis Treatment.
The Liver Fibrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liver Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences, Inc.
Merck & Co., Inc.
Bristol-Myers Squibb
Johnson and Johnson
Novartis AG
Vertex Pharmaceuticals Incorporated
Pfizer Inc.
FibroGen, Inc.
Pharmaxis Limited
Segment by Type
PPARa Agonist
ACE Inhibitors
Hepatotropic Drug
Others
Segment by Application
Alcoholic Liver Disease
Chronic Viral Hepatitis
Non-alcoholic Fatty Liver Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Fibrosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liver Fibrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Fibrosis Treatment.
The Liver Fibrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liver Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences, Inc.
Merck & Co., Inc.
Bristol-Myers Squibb
Johnson and Johnson
Novartis AG
Vertex Pharmaceuticals Incorporated
Pfizer Inc.
FibroGen, Inc.
Pharmaxis Limited
Segment by Type
PPARa Agonist
ACE Inhibitors
Hepatotropic Drug
Others
Segment by Application
Alcoholic Liver Disease
Chronic Viral Hepatitis
Non-alcoholic Fatty Liver Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Fibrosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Fibrosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PPARa Agonist
1.2.3 ACE Inhibitors
1.2.4 Hepatotropic Drug
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liver Fibrosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Alcoholic Liver Disease
1.3.3 Chronic Viral Hepatitis
1.3.4 Non-alcoholic Fatty Liver Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Fibrosis Treatment Market Perspective (2020-2031)
2.2 Global Liver Fibrosis Treatment Growth Trends by Region
2.2.1 Global Liver Fibrosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liver Fibrosis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Liver Fibrosis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Liver Fibrosis Treatment Market Dynamics
2.3.1 Liver Fibrosis Treatment Industry Trends
2.3.2 Liver Fibrosis Treatment Market Drivers
2.3.3 Liver Fibrosis Treatment Market Challenges
2.3.4 Liver Fibrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Fibrosis Treatment Players by Revenue
3.1.1 Global Top Liver Fibrosis Treatment Players by Revenue (2020-2025)
3.1.2 Global Liver Fibrosis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Liver Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liver Fibrosis Treatment Revenue
3.4 Global Liver Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Liver Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Fibrosis Treatment Revenue in 2024
3.5 Global Key Players of Liver Fibrosis Treatment Head office and Area Served
3.6 Global Key Players of Liver Fibrosis Treatment, Product and Application
3.7 Global Key Players of Liver Fibrosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Fibrosis Treatment Breakdown Data by Type
4.1 Global Liver Fibrosis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Liver Fibrosis Treatment Forecasted Market Size by Type (2026-2031)
5 Liver Fibrosis Treatment Breakdown Data by Application
5.1 Global Liver Fibrosis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Liver Fibrosis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liver Fibrosis Treatment Market Size (2020-2031)
6.2 North America Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liver Fibrosis Treatment Market Size by Country (2020-2025)
6.4 North America Liver Fibrosis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Fibrosis Treatment Market Size (2020-2031)
7.2 Europe Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liver Fibrosis Treatment Market Size by Country (2020-2025)
7.4 Europe Liver Fibrosis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Fibrosis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Liver Fibrosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Fibrosis Treatment Market Size (2020-2031)
9.2 Latin America Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liver Fibrosis Treatment Market Size by Country (2020-2025)
9.4 Latin America Liver Fibrosis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Fibrosis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. Liver Fibrosis Treatment Introduction
11.1.4 Gilead Sciences, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Liver Fibrosis Treatment Introduction
11.2.4 Merck & Co., Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Liver Fibrosis Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Details
11.4.2 Johnson and Johnson Business Overview
11.4.3 Johnson and Johnson Liver Fibrosis Treatment Introduction
11.4.4 Johnson and Johnson Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.4.5 Johnson and Johnson Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Liver Fibrosis Treatment Introduction
11.5.4 Novartis AG Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.5.5 Novartis AG Recent Development
11.6 Vertex Pharmaceuticals Incorporated
11.6.1 Vertex Pharmaceuticals Incorporated Company Details
11.6.2 Vertex Pharmaceuticals Incorporated Business Overview
11.6.3 Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Introduction
11.6.4 Vertex Pharmaceuticals Incorporated Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.6.5 Vertex Pharmaceuticals Incorporated Recent Development
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Details
11.7.2 Pfizer Inc. Business Overview
11.7.3 Pfizer Inc. Liver Fibrosis Treatment Introduction
11.7.4 Pfizer Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.7.5 Pfizer Inc. Recent Development
11.8 FibroGen, Inc.
11.8.1 FibroGen, Inc. Company Details
11.8.2 FibroGen, Inc. Business Overview
11.8.3 FibroGen, Inc. Liver Fibrosis Treatment Introduction
11.8.4 FibroGen, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.8.5 FibroGen, Inc. Recent Development
11.9 Pharmaxis Limited
11.9.1 Pharmaxis Limited Company Details
11.9.2 Pharmaxis Limited Business Overview
11.9.3 Pharmaxis Limited Liver Fibrosis Treatment Introduction
11.9.4 Pharmaxis Limited Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.9.5 Pharmaxis Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Fibrosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PPARa Agonist
1.2.3 ACE Inhibitors
1.2.4 Hepatotropic Drug
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liver Fibrosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Alcoholic Liver Disease
1.3.3 Chronic Viral Hepatitis
1.3.4 Non-alcoholic Fatty Liver Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Fibrosis Treatment Market Perspective (2020-2031)
2.2 Global Liver Fibrosis Treatment Growth Trends by Region
2.2.1 Global Liver Fibrosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liver Fibrosis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Liver Fibrosis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Liver Fibrosis Treatment Market Dynamics
2.3.1 Liver Fibrosis Treatment Industry Trends
2.3.2 Liver Fibrosis Treatment Market Drivers
2.3.3 Liver Fibrosis Treatment Market Challenges
2.3.4 Liver Fibrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Fibrosis Treatment Players by Revenue
3.1.1 Global Top Liver Fibrosis Treatment Players by Revenue (2020-2025)
3.1.2 Global Liver Fibrosis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Liver Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liver Fibrosis Treatment Revenue
3.4 Global Liver Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Liver Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Fibrosis Treatment Revenue in 2024
3.5 Global Key Players of Liver Fibrosis Treatment Head office and Area Served
3.6 Global Key Players of Liver Fibrosis Treatment, Product and Application
3.7 Global Key Players of Liver Fibrosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Fibrosis Treatment Breakdown Data by Type
4.1 Global Liver Fibrosis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Liver Fibrosis Treatment Forecasted Market Size by Type (2026-2031)
5 Liver Fibrosis Treatment Breakdown Data by Application
5.1 Global Liver Fibrosis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Liver Fibrosis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liver Fibrosis Treatment Market Size (2020-2031)
6.2 North America Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liver Fibrosis Treatment Market Size by Country (2020-2025)
6.4 North America Liver Fibrosis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Fibrosis Treatment Market Size (2020-2031)
7.2 Europe Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liver Fibrosis Treatment Market Size by Country (2020-2025)
7.4 Europe Liver Fibrosis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Fibrosis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Liver Fibrosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Fibrosis Treatment Market Size (2020-2031)
9.2 Latin America Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liver Fibrosis Treatment Market Size by Country (2020-2025)
9.4 Latin America Liver Fibrosis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Fibrosis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Liver Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. Liver Fibrosis Treatment Introduction
11.1.4 Gilead Sciences, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Liver Fibrosis Treatment Introduction
11.2.4 Merck & Co., Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Liver Fibrosis Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Details
11.4.2 Johnson and Johnson Business Overview
11.4.3 Johnson and Johnson Liver Fibrosis Treatment Introduction
11.4.4 Johnson and Johnson Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.4.5 Johnson and Johnson Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Liver Fibrosis Treatment Introduction
11.5.4 Novartis AG Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.5.5 Novartis AG Recent Development
11.6 Vertex Pharmaceuticals Incorporated
11.6.1 Vertex Pharmaceuticals Incorporated Company Details
11.6.2 Vertex Pharmaceuticals Incorporated Business Overview
11.6.3 Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Introduction
11.6.4 Vertex Pharmaceuticals Incorporated Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.6.5 Vertex Pharmaceuticals Incorporated Recent Development
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Details
11.7.2 Pfizer Inc. Business Overview
11.7.3 Pfizer Inc. Liver Fibrosis Treatment Introduction
11.7.4 Pfizer Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.7.5 Pfizer Inc. Recent Development
11.8 FibroGen, Inc.
11.8.1 FibroGen, Inc. Company Details
11.8.2 FibroGen, Inc. Business Overview
11.8.3 FibroGen, Inc. Liver Fibrosis Treatment Introduction
11.8.4 FibroGen, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.8.5 FibroGen, Inc. Recent Development
11.9 Pharmaxis Limited
11.9.1 Pharmaxis Limited Company Details
11.9.2 Pharmaxis Limited Business Overview
11.9.3 Pharmaxis Limited Liver Fibrosis Treatment Introduction
11.9.4 Pharmaxis Limited Revenue in Liver Fibrosis Treatment Business (2020-2025)
11.9.5 Pharmaxis Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Liver Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PPARa Agonist
Table 3. Key Players of ACE Inhibitors
Table 4. Key Players of Hepatotropic Drug
Table 5. Key Players of Others
Table 6. Global Liver Fibrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liver Fibrosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Liver Fibrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Liver Fibrosis Treatment Market Share by Region (2020-2025)
Table 10. Global Liver Fibrosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Liver Fibrosis Treatment Market Share by Region (2026-2031)
Table 12. Liver Fibrosis Treatment Market Trends
Table 13. Liver Fibrosis Treatment Market Drivers
Table 14. Liver Fibrosis Treatment Market Challenges
Table 15. Liver Fibrosis Treatment Market Restraints
Table 16. Global Liver Fibrosis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Liver Fibrosis Treatment Market Share by Players (2020-2025)
Table 18. Global Top Liver Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Fibrosis Treatment as of 2024)
Table 19. Ranking of Global Top Liver Fibrosis Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Liver Fibrosis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Liver Fibrosis Treatment, Headquarters and Area Served
Table 22. Global Key Players of Liver Fibrosis Treatment, Product and Application
Table 23. Global Key Players of Liver Fibrosis Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liver Fibrosis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Liver Fibrosis Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Liver Fibrosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Liver Fibrosis Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Liver Fibrosis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Liver Fibrosis Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Liver Fibrosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Liver Fibrosis Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Liver Fibrosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Gilead Sciences, Inc. Company Details
Table 49. Gilead Sciences, Inc. Business Overview
Table 50. Gilead Sciences, Inc. Liver Fibrosis Treatment Product
Table 51. Gilead Sciences, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 52. Gilead Sciences, Inc. Recent Development
Table 53. Merck & Co., Inc. Company Details
Table 54. Merck & Co., Inc. Business Overview
Table 55. Merck & Co., Inc. Liver Fibrosis Treatment Product
Table 56. Merck & Co., Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 57. Merck & Co., Inc. Recent Development
Table 58. Bristol-Myers Squibb Company Details
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Liver Fibrosis Treatment Product
Table 61. Bristol-Myers Squibb Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 62. Bristol-Myers Squibb Recent Development
Table 63. Johnson and Johnson Company Details
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Liver Fibrosis Treatment Product
Table 66. Johnson and Johnson Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 67. Johnson and Johnson Recent Development
Table 68. Novartis AG Company Details
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Liver Fibrosis Treatment Product
Table 71. Novartis AG Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 72. Novartis AG Recent Development
Table 73. Vertex Pharmaceuticals Incorporated Company Details
Table 74. Vertex Pharmaceuticals Incorporated Business Overview
Table 75. Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Product
Table 76. Vertex Pharmaceuticals Incorporated Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 77. Vertex Pharmaceuticals Incorporated Recent Development
Table 78. Pfizer Inc. Company Details
Table 79. Pfizer Inc. Business Overview
Table 80. Pfizer Inc. Liver Fibrosis Treatment Product
Table 81. Pfizer Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 82. Pfizer Inc. Recent Development
Table 83. FibroGen, Inc. Company Details
Table 84. FibroGen, Inc. Business Overview
Table 85. FibroGen, Inc. Liver Fibrosis Treatment Product
Table 86. FibroGen, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 87. FibroGen, Inc. Recent Development
Table 88. Pharmaxis Limited Company Details
Table 89. Pharmaxis Limited Business Overview
Table 90. Pharmaxis Limited Liver Fibrosis Treatment Product
Table 91. Pharmaxis Limited Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 92. Pharmaxis Limited Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Liver Fibrosis Treatment Picture
Figure 2. Global Liver Fibrosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liver Fibrosis Treatment Market Share by Type: 2024 VS 2031
Figure 4. PPARa Agonist Features
Figure 5. ACE Inhibitors Features
Figure 6. Hepatotropic Drug Features
Figure 7. Others Features
Figure 8. Global Liver Fibrosis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Liver Fibrosis Treatment Market Share by Application: 2024 VS 2031
Figure 10. Alcoholic Liver Disease Case Studies
Figure 11. Chronic Viral Hepatitis Case Studies
Figure 12. Non-alcoholic Fatty Liver Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Liver Fibrosis Treatment Report Years Considered
Figure 15. Global Liver Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Liver Fibrosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Liver Fibrosis Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Liver Fibrosis Treatment Market Share by Players in 2024
Figure 19. Global Top Liver Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Fibrosis Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Liver Fibrosis Treatment Revenue in 2024
Figure 21. North America Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 23. United States Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 27. Germany Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Liver Fibrosis Treatment Market Share by Region (2020-2031)
Figure 35. China Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Gilead Sciences, Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 51. Merck & Co., Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 53. Johnson and Johnson Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 54. Novartis AG Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 55. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 56. Pfizer Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 57. FibroGen, Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 58. Pharmaxis Limited Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Liver Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PPARa Agonist
Table 3. Key Players of ACE Inhibitors
Table 4. Key Players of Hepatotropic Drug
Table 5. Key Players of Others
Table 6. Global Liver Fibrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liver Fibrosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Liver Fibrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Liver Fibrosis Treatment Market Share by Region (2020-2025)
Table 10. Global Liver Fibrosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Liver Fibrosis Treatment Market Share by Region (2026-2031)
Table 12. Liver Fibrosis Treatment Market Trends
Table 13. Liver Fibrosis Treatment Market Drivers
Table 14. Liver Fibrosis Treatment Market Challenges
Table 15. Liver Fibrosis Treatment Market Restraints
Table 16. Global Liver Fibrosis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Liver Fibrosis Treatment Market Share by Players (2020-2025)
Table 18. Global Top Liver Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Fibrosis Treatment as of 2024)
Table 19. Ranking of Global Top Liver Fibrosis Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Liver Fibrosis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Liver Fibrosis Treatment, Headquarters and Area Served
Table 22. Global Key Players of Liver Fibrosis Treatment, Product and Application
Table 23. Global Key Players of Liver Fibrosis Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liver Fibrosis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Liver Fibrosis Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Liver Fibrosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Liver Fibrosis Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Liver Fibrosis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Liver Fibrosis Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Liver Fibrosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Liver Fibrosis Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Liver Fibrosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Liver Fibrosis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Liver Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Liver Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Gilead Sciences, Inc. Company Details
Table 49. Gilead Sciences, Inc. Business Overview
Table 50. Gilead Sciences, Inc. Liver Fibrosis Treatment Product
Table 51. Gilead Sciences, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 52. Gilead Sciences, Inc. Recent Development
Table 53. Merck & Co., Inc. Company Details
Table 54. Merck & Co., Inc. Business Overview
Table 55. Merck & Co., Inc. Liver Fibrosis Treatment Product
Table 56. Merck & Co., Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 57. Merck & Co., Inc. Recent Development
Table 58. Bristol-Myers Squibb Company Details
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Liver Fibrosis Treatment Product
Table 61. Bristol-Myers Squibb Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 62. Bristol-Myers Squibb Recent Development
Table 63. Johnson and Johnson Company Details
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Liver Fibrosis Treatment Product
Table 66. Johnson and Johnson Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 67. Johnson and Johnson Recent Development
Table 68. Novartis AG Company Details
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Liver Fibrosis Treatment Product
Table 71. Novartis AG Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 72. Novartis AG Recent Development
Table 73. Vertex Pharmaceuticals Incorporated Company Details
Table 74. Vertex Pharmaceuticals Incorporated Business Overview
Table 75. Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Product
Table 76. Vertex Pharmaceuticals Incorporated Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 77. Vertex Pharmaceuticals Incorporated Recent Development
Table 78. Pfizer Inc. Company Details
Table 79. Pfizer Inc. Business Overview
Table 80. Pfizer Inc. Liver Fibrosis Treatment Product
Table 81. Pfizer Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 82. Pfizer Inc. Recent Development
Table 83. FibroGen, Inc. Company Details
Table 84. FibroGen, Inc. Business Overview
Table 85. FibroGen, Inc. Liver Fibrosis Treatment Product
Table 86. FibroGen, Inc. Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 87. FibroGen, Inc. Recent Development
Table 88. Pharmaxis Limited Company Details
Table 89. Pharmaxis Limited Business Overview
Table 90. Pharmaxis Limited Liver Fibrosis Treatment Product
Table 91. Pharmaxis Limited Revenue in Liver Fibrosis Treatment Business (2020-2025) & (US$ Million)
Table 92. Pharmaxis Limited Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Liver Fibrosis Treatment Picture
Figure 2. Global Liver Fibrosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liver Fibrosis Treatment Market Share by Type: 2024 VS 2031
Figure 4. PPARa Agonist Features
Figure 5. ACE Inhibitors Features
Figure 6. Hepatotropic Drug Features
Figure 7. Others Features
Figure 8. Global Liver Fibrosis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Liver Fibrosis Treatment Market Share by Application: 2024 VS 2031
Figure 10. Alcoholic Liver Disease Case Studies
Figure 11. Chronic Viral Hepatitis Case Studies
Figure 12. Non-alcoholic Fatty Liver Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Liver Fibrosis Treatment Report Years Considered
Figure 15. Global Liver Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Liver Fibrosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Liver Fibrosis Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Liver Fibrosis Treatment Market Share by Players in 2024
Figure 19. Global Top Liver Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Fibrosis Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Liver Fibrosis Treatment Revenue in 2024
Figure 21. North America Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 23. United States Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 27. Germany Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Liver Fibrosis Treatment Market Share by Region (2020-2031)
Figure 35. China Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Liver Fibrosis Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Liver Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Gilead Sciences, Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 51. Merck & Co., Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 53. Johnson and Johnson Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 54. Novartis AG Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 55. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 56. Pfizer Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 57. FibroGen, Inc. Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 58. Pharmaxis Limited Revenue Growth Rate in Liver Fibrosis Treatment Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232